NCT02443493

Laser Therapy for the Prevention of Radiodermatitis in Breast Cancer Patients

Low-level Laser Therapy as a Tool for the Prevention of Radiodermatitis in Breast Cancer Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 139 (actual)
• Sponsor: Hasselt University · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

Up to 90% of the radiotherapy patients will develop a certain degree of skin reaction at the treated area, also known as radiodermatitis (RD). Currently, there is a wide variety of strategies to manage RD, including creams, gels, ointments, wound dressings. However, up to now, there is still no comprehensive, evidence-based consensus for the treatment of RD. Low-level laser therapy (LLLT) is a promising, non-invasive technique for treating RD. In a recent pilot study conducted in our research group, LLLT prevented the aggravation of RD and provided symptomatic relief in patients undergoing radiotherapy for breast cancer after breast-sparing surgery. This pilot study was the first prospective study investigating the potential of LLLT for RD. In the current study, we want to investigate the efficacy of LLLT as a tool for the prevention of radiodermatitis in breast cancer patients.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
DEVICE	Low-level laser	Low-Level Laser Therapy will be applied, twice a week, from the start of radiotherapy treatment (14 sessions in total) in combination with the standard skin care.
DEVICE	sham laser	Sham Laser Therapy will be applied, twice a week, from the start of radiotherapy treatment (14 sessions in total) in combination with the standard skin care.
RADIATION	radiotherapy

Timeline

• Start date: 2015-04-01
• Primary completion: 2017-06-01
• Completion: 2017-06-01
• First posted: 2015-05-13
• Last updated: 2019-07-26

Locations

1 site across 1 country: Belgium